Synthetic peptide conjugated to KLH, corresponding to a region within C terminal amino acids 460-489 of Human LMBR1L.
- 293 cell lysate; Human breast carcinoma tissue.
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Immunogen affinity purified
ab103458 is purified through a protein A column, followed by peptide affinity purification.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/100 - 1/500. Predicted molecular weight: 55 kDa.
||1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
LMBR1L is a probable LCN1 receptor and may mediate LCN1 endocytosis.
Cell Membrane; Multi-pass membrane protein.
- FLJ10494 antibody
- FLJ36251 antibody
- KIAA1174 antibody
Western blot - LMBR1L antibody (ab103458)
Anti-LMBR1L antibody (ab103458) at 1/100 dilution + 293 cell lysate at 35 µg
Predicted band size: 55 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - LMBR1L antibody (ab103458)
ab103458, at 1/50 dilution, staining LMBR1L in formalin-fixed, paraffin-embedded Human breast carcinoma by Immunohistochemistry using a peroxidase conjugated secondary antibody and DAB staining.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"